Ling Karen
- SEC CIK
- 0001597450
In the past year, 1 open-market purchase filing worth $71.0K and no sales.
Current role at each company
- IRTC iRhythm Holdings, Inc.Directoras of May 29, 2026
- BLCO Bausch & Lomb CorpDirectoras of May 28, 2026
- MNKTQ Keenova Therapeutics plcDirectoras of Nov 16, 2023
- TXMD TherapeuticsMD, Inc.Directoras of Oct 3, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $71.0K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$71.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Ling Karen as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BLCO Bausch & Lomb Corp
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2026 (view filing) | Feb 19 | 4 days | Ling KarenDirector | PPurchaseCommon Shares, No Par Value | +4.00K | $17.74 | +$71.0K | +10.6%41.7K after |
TXMD TherapeuticsMD, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2021 (view filing) | Aug 17 | 2 days | Ling KarenDirector | PPurchase | +33.4K | $0.75 | +$25.1K | +34.5%130.3K after |